Biotechnology: Principles and Processes

The chapter follows the order the discipline developed in. Section 9.1, "Principles of Biotechnology," lays the groundwork: the two core techniques, why alien DNA needs an origin of replication to be inherited, and the 1972 Cohen-Boyer experiment that defined the three basic steps of genetically modifying an organism. Section 9.2, "Tools of Recombinant DNA Technology," introduces the molecular toolkit — restriction enzymes, gel electrophoresis, the essential features of a cloning vector (pBR322), the two strategies for selecting recombinants, specialised vectors for plants and animals, and how a host is made "competent." Section 9.3, "Processes of Recombinant DNA Technology," walks the complete pipeline: isolating DNA, cutting it, amplifying by PCR, inserting recombinant DNA into the host, obtaining the gene product, and downstream processing before market. The "core ideas" section below follows this sequence, and the three derivations dramatise its richest moments: constructing and selecting a recombinant plasmid, making a bacterium competent, and running a PCR cycle.

The two pillars: genetic engineering and bioprocess engineering

Biotechnology, broadly, is any use of live organisms or their enzymes to make products useful to humans — by that definition, making curd, bread or wine would count. In the restricted, modern sense this chapter uses, biotechnology means processes that use genetically modified organisms to achieve useful outcomes at large scale, and also includes techniques such as in vitro fertilisation, DNA vaccines and gene correction. The European Federation of Biotechnology defines it as "the integration of natural science and organisms, cells, parts thereof, and molecular analogues for products and services." Two techniques are the true engines here. Genetic engineering alters the chemistry of DNA and RNA, introduces it into host organisms, and thereby changes the host's phenotype. Bioprocess engineering maintains a sterile, contamination-free environment in a chemical engineering process so only the desired microbe or eukaryotic cell grows, in bulk, to manufacture products like antibiotics, vaccines and enzymes. Genetic engineering builds the modified organism; bioprocess engineering grows it industrially — neither alone is biotechnology in this chapter's sense.

Why an alien gene needs an origin of replication

Sexual reproduction generates variation that asexual reproduction cannot; traditional hybridisation exploits this but is blunt, often carrying undesirable genes along with desired ones. Genetic engineering — recombinant DNA, gene cloning, gene transfer — overcomes this by letting us isolate and introduce only chosen genes. A piece of DNA transferred into an alien organism, left on its own, will most likely not multiply in progeny cells at all. If it becomes part of a chromosome, however, it can multiply and be inherited along with the host's DNA, because a chromosome carries a specific sequence, the origin of replication (ori), that initiates replication. So any alien DNA needs to be linked to an ori to multiply inside a host — this is why recombinant technology stitches a gene onto something that already knows how to replicate. Making multiple identical copies of a template DNA this way is called cloning.

The first recombinant DNA molecule: Cohen and Boyer, 1972

The first artificial recombinant DNA molecule came from linking a gene for antibiotic resistance to a native plasmid (an autonomously replicating, circular, extra-chromosomal DNA) of Salmonella typhimurium. Stanley Cohen and Herbert Boyer achieved this in 1972: they cut the antibiotic-resistance gene out of a plasmid using a newly discovered restriction enzyme, then linked it to a plasmid vector (much as a mosquito vectors the malarial parasite) using DNA ligase, which joins the ends of cut DNA. The result — a new, in-vitro combination of circular, autonomously replicating DNA — is recombinant DNA. Transferred into E. coli, it replicated using the host's own DNA polymerase, multiplying the resistance gene: the first instance of gene cloning. From this, NCERT draws the three basic steps of genetically modifying any organism: identification of DNA with the desirable gene; introduction of that DNA into the host; and maintenance of the introduced DNA in the host and its transfer to progeny. Every later technique serves one of these three steps.

Restriction enzymes: molecular scissors that read palindromes

In 1963, two enzymes restricting bacteriophage growth in E. coli were isolated: one methylated DNA, the other cut it — the restriction endonuclease. Five years later the first sequence-specific one, Hind II, was characterised, cutting DNA at a point defined by a specific six-base-pair recognition sequence. Today over 900 restriction enzymes are known from 230-plus bacterial strains. Naming follows a fixed convention: first letter from the genus, next two from the species — EcoRI comes from Escherichia coli RY13 (R from the strain), and Roman numerals record isolation order. Restriction enzymes are nucleases: exonucleases remove nucleotides from DNA ends, endonucleases cut at internal positions. A restriction endonuclease scans DNA for its recognition sequence, then cuts both strands at specific points in the sugar-phosphate backbone. That sequence is a palindrome — reading the same on both strands, 5' to 3', like "MALAYALAM": 5' — G A A T T C — 3' 3' — C T T A A G — 5' This is EcoRI's site. Restriction enzymes cut a little from the palindrome's centre, but at the same two bases on each strand, leaving overhanging single strands — sticky ends — named for their ability to hydrogen-bond with any complementary sticky end, including one from a different DNA source cut by the same enzyme. This stickiness lets DNA ligase join fragments efficiently and specifically. It follows that unless vector and source DNA are cut with the same enzyme, sticky ends will not match and no recombinant molecule can form.

Separating and visualising DNA: gel electrophoresis

Restriction digestion produces a mixture of fragments needing separation. Gel electrophoresis does this: DNA is negatively charged and moves toward the anode under an electric field, through an agarose matrix (a natural sea-weed polymer) whose sieving effect makes smaller fragments move farther, resolving the mix into size-ordered bands. Bands are invisible in normal light; they are stained with ethidium bromide and viewed as bright orange bands under UV. A desired band is cut out and its DNA extracted — a step called elution — ready to be joined with a vector.

Cloning vectors: what a vector must have

Plasmids and bacteriophages replicate inside bacteria independently of chromosomal DNA — plasmids from one or two copies per cell up to 15-100 or more. Linking an alien gene to such a plasmid multiplies it to the same copy number. Present-day vectors are engineered with three essential features. Origin of replication (ori): the sequence from which replication starts, controlling copy number — a high-copy-number ori is chosen when many copies of the target DNA are wanted. Selectable marker: identifies and eliminates non-transformants while allowing transformants (cells that took up the vector, via transformation) to grow — usually genes for resistance to ampicillin, chloramphenicol, tetracycline or kanamycin, since normal E. coli resists none of these. Cloning sites: restriction sites in the vector, preferably just one per commonly used enzyme — more than one would generate several fragments and complicate cloning. The classic teaching vector is E. coli's pBR322, carrying sites HindIII, EcoRI, BamHI, SalI, PvuII, PstI, ClaI, an ori, and two resistance genes, ampR and tetR, plus rop, which helps regulate the plasmid's copy number.

Selecting recombinants from non-recombinants

A vector with a marker only solves half the problem — the researcher must still tell which host cells took up recombinant DNA. In pBR322, ligating foreign DNA at the BamHI site inside tetR destroys that gene by insertional inactivation: recombinant plasmids confer ampicillin resistance but not tetracycline resistance. Cells are first plated on ampicillin (only transformants, recombinant or not, survive); surviving colonies are then transferred to tetracycline. Recombinants grow on ampicillin but not tetracycline; non-recombinants (self-ligated, insert-free vector) grow on both. One gene (ampR) selects transformants from untransformed cells; the other (tetR), through inactivation, selects recombinants from non-recombinants. Because this two-plate procedure is cumbersome, a faster scheme inserts the foreign DNA within the coding sequence of beta-galactosidase. On medium with its chromogenic substrate, an intact enzyme turns colonies blue; an insert disrupts the gene (insertional inactivation), so recombinant colonies stay colourless — identified on a single plate as blue-white screening.

Vectors for plants and animals, and making the host competent

Agrobacterium tumefaciens, a dicot pathogen, naturally delivers a DNA piece called T-DNA into plant cells, transforming them into a tumour; retroviruses in animals naturally transform cells into cancerous ones. Biotechnologists have disarmed both: the Ti (tumour-inducing) plasmid of A. tumefaciens, no longer pathogenic, still delivers genes of interest into many plant species, and disarmed retroviruses deliver genes into animal cells. DNA is hydrophilic and cannot cross a cell membrane unaided, so bacterial cells must first be made "competent" — treated with a divalent cation such as calcium, which increases DNA uptake through pores in the cell wall. Recombinant DNA is then forced in by incubating cells and DNA together on ice, briefly applying a 42°C heat shock, and returning to ice. Alternatives include micro-injection (DNA injected directly into an animal cell's nucleus), biolistics/gene gun (cells bombarded with DNA-coated gold or tungsten micro-particles, for plants), and infection by a disarmed pathogen vector.

The processes of recombinant DNA technology, in sequence

The full pipeline follows a fixed order: isolate the DNA, cut it at specific locations, amplify the gene of interest by PCR, ligate it into a vector, insert the recombinant DNA into a host, culture the host at scale, and extract the product by downstream processing. Isolation requires breaking the cell open, releasing DNA tangled with RNA, proteins, polysaccharides and lipids. Enzymes break the wall or membrane — lysozyme (bacteria), cellulase (plant cells), chitinase (fungi) — after which ribonuclease removes RNA and protease removes protein; pure DNA precipitates on adding chilled ethanol, visible as fine spoolable threads. The purified DNA is digested with the chosen restriction enzyme under optimal conditions, checked by gel electrophoresis, and the same enzyme cuts the vector. The cut gene of interest and cut vector are mixed with DNA ligase, producing recombinant DNA.

Amplification of the gene of interest using PCR

PCR (polymerase chain reaction) synthesises multiple copies of a gene in vitro using two short primers complementary to the flanking regions, plus DNA polymerase. Each cycle has three steps: denaturation (heat separates the double strand), primer annealing (cooling lets primers bind their complementary sites), and extension (polymerase extends each primer using supplied nucleotides and the genomic DNA as template). Repeating the cycle roughly doubles the DNA each time, amplifying it to about a billion copies within hours. This repeated heating is possible only because PCR uses a thermostable DNA polymerase, from Thermus aquaticus ("Taq polymerase"), which survives repeated denaturation without being destroyed. The amplified fragment can then be ligated into a vector for further cloning.

Insertion into the host, bioreactors and downstream processing

Once recombinant DNA bearing an antibiotic-resistance gene (say, ampicillin resistance) transforms E. coli, plating on ampicillin lets only transformants survive — the resistance gene serves as the selectable marker. The usual aim is a desirable protein, so the gene of interest must be expressed; a gene expressed in a host other than its natural source gives a recombinant protein. Small cultures yield too little product; a continuous culture system, draining spent medium while adding fresh, keeps cells in their active log phase for higher yield. Producing useful quantities needs 100-1000 litre culture volumes — a bioreactor, a vessel converting raw materials into a specific product using microbial, plant, animal or human cells, supplying optimum temperature, pH, substrate, salts, vitamins and oxygen. The commonest design is the stirred-tank bioreactor, cylindrical or curved-based for mixing, with an agitator, an oxygen-delivery system (sometimes sparging sterile air through, giving a sparged stirred-tank bioreactor), foam control, temperature and pH control, and sampling ports — far better aeration, mixing and control than any shake flask offers.

After the biosynthetic stage, the product goes through downstream processing: separation and purification, formulation with preservatives, and, for drugs, clinical trials and strict quality-control testing before market. No biotechnological product skips this stage.

Board level - Identify a palindromic recognition sequence and predict the products of EcoRI digestion

A student is given the double-stranded sequence 5'-CTGAATTCAG-3' paired with its complementary strand. (a) Locate the EcoRI recognition sequence within it. (b) State why this sequence qualifies as a palindrome. (c) Describe the two fragments produced after EcoRI cuts, and explain why they can be rejoined to a vector cut with the same enzyme.

Step 1. Scan for EcoRI's recognition sequence, GAATTC. Reading 5'-CTGAATTCAG-3', GAATTC sits in the middle: CT-GAATTC-AG.

Step 2. Check the complementary strand: the complement of 5'-GAATTC-3' is 3'-CTTAAG-5', which read 5' to 3' is again GAATTC. Both strands read the same sequence 5' to 3', so GAATTC is a palindrome, like MALAYALAM read forwards and backwards.

Step 3. EcoRI cuts between G and the first A on each strand, a little from the palindrome's centre but at the same position on both strands, producing two fragments each carrying a four-base overhang, AATT, complementary to the AATT on the other fragment — the sticky ends.

Step 4. Any other fragment cut by EcoRI carries the identical AATT sticky end, so it can base-pair with either fragment here, and ligase can seal the joint. This is why a vector must be cut with the same enzyme as the source DNA. Answer: the recognition sequence is GAATTC, a palindrome since both strands read GAATTC 5' to 3'; EcoRI cuts between G and A on each strand, leaving two fragments with complementary AATT sticky ends that can be ligated to any other EcoRI-cut fragment.

Board level - Distinguish transformants from recombinants using blue-white (chromogenic) screening

A gene of interest is inserted, using a restriction enzyme, into a vector at a site within the beta-galactosidase coding sequence. The ligation mixture transforms bacteria, plated on a medium containing the chromogenic substrate for beta-galactosidase. Explain what colour recombinant and non-recombinant colonies show, and why.

Step 1. An intact beta-galactosidase gene, in the presence of the chromogenic substrate, makes an enzyme that converts the substrate to a blue product — any colony with an intact, functional gene turns blue.

Step 2. A bacterium with a self-ligated, insert-free vector (non-recombinant) has an undisturbed beta-galactosidase gene: the enzyme is made, the substrate is converted, and the colony is blue.

Step 3. A bacterium with the foreign gene inserted inside beta-galactosidase (a recombinant) has its reading frame disrupted — insertional inactivation — so no functional enzyme forms, the substrate is not converted, and the colony stays colourless.

Step 4. A researcher can scan one plate by eye and pick only white colonies as candidate recombinants, avoiding the two-plate ampicillin/tetracycline procedure. Answer: non-recombinant colonies (intact beta-galactosidase) turn blue; recombinant colonies (beta-galactosidase disrupted by the insert) stay colourless.

Competitive level (NEET) - Calculate the number of PCR copies produced after a given number of cycles

A PCR reaction begins with a single double-stranded template, and each cycle doubles the target DNA. (a) How many copies exist after 10 cycles? (b) Approximately how many cycles reach about one billion ($10^{9}$) copies, and does this match PCR's stated amplification factor?

Step 1. From one template, after $n$ cycles, $$\text{copies} = 2^{n},$$ since every existing double strand is denatured and copied once per cycle, doubling the total each time.

Step 2. For $n = 10$: $2^{10} = 1024 \approx 1.0 \times 10^{3}$ copies — roughly a thousand-fold amplification.

Step 3. We need the smallest $n$ with $2^{n} \approx 10^{9}$. Using $2^{10} \approx 10^{3}$: $2^{30} = (2^{10})^{3} \approx 10^{9}$. So about $n = 30$ cycles — within the typical PCR range of 25 to 35.

Step 4. NCERT states PCR amplifies DNA "to approximately billion times, i.e., 1 billion copies are made." Our $2^{30} \approx 1.07 \times 10^{9}$ matches this almost exactly. Answer: after 10 cycles, about 1024 ($\approx 10^{3}$) copies; about 30 cycles reach roughly $10^{9}$ copies, matching NCERT's stated billion-fold amplification. Timing note: under 90 seconds. Keep $2^{10} \approx 10^{3}$ memorised — it converts any power of two into a power of ten instantly ($2^{20} \approx 10^{6}$, $2^{30} \approx 10^{9}$). The trap is starting the count wrong: "after $n$ cycles" means $n$ full rounds completed, giving $2^{n}$ copies, not $2^{n-1}$ or $2^{n+1}$.

Most lost marks are not ignorance of the tools but confusion about which piece of machinery does which job — cutting versus joining, selecting transformants versus recombinants, one antibiotic gene versus the other. The confusion is most concentrated in pBR322's dual-antibiotic selection scheme.

• State biotechnology's two core techniques, genetic engineering and bioprocess engineering, and why both are needed.
• Explain why alien DNA needs an origin of replication to be inherited in a host.
• Describe how a restriction endonuclease recognises a palindrome and produces sticky ends, and apply the naming convention (e.g. EcoRI).
• Explain gel electrophoresis: why DNA moves toward the anode, how bands are visualised, and what elution recovers.
• List the three essential features of a cloning vector using pBR322 as an example.
• Distinguish antibiotic-based selection (tetR inactivation) from blue-white, chromogenic selection (beta-galactosidase).
• Describe how a bacterial host is made competent and the alternative delivery methods for plant/animal cells.
• Explain the three PCR steps and calculate copies after a given number of cycles using $2^{n}$.
• Describe a bioreactor's role and what downstream processing includes.

Ask the tutor: Want to work through how these exact tools — restriction enzymes, PCR, bioreactors — get applied to insulin, Bt cotton and gene therapy in the next chapter?